That does not seem so strange to me. Fair valuation of biological assets is up by $67 million, only last year it was a bit more ie $83 million. Thus the difference is a decline of 20%. However the assets are up in aggregate and NTA is up by 19%.
TFC Price at posting:
$1.50 Sentiment: Buy Disclosure: Held
